Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Paragonix Technologies, Inc.

Vanderbilt Health Performs First Successful Kidney Transplant Using New Organ Preservation Technology
From Paragonix Technologies, Inc.
Via Business Wire
Paragonix to Showcase Extensive Organ Transplant Research at the 45th Annual Meeting of the International Society of Heart and Lung Transplantation
From Paragonix Technologies, Inc.
Via Business Wire
Breakthrough Cardiac Study Reveals Long-Term Impact on Post-Transplant Survival: A 2-Year Clinical Investigation Advancing Heart Preservation
From Paragonix Technologies, Inc.
Via Business Wire
Paragonix LUNGguard System Shown to Reduce Post-Transplant Complications in Lung Transplant Recipients
From Paragonix Technologies, Inc.
Via Business Wire
Paragonix Technologies Announces Nationwide Commercial Availability of FDA-Cleared BAROguard™ Donor Lung Preservation System
From Paragonix Technologies, Inc.
Via Business Wire
Paragonix Presenting Expansive Organ Transplant Research at the International Society of Heart and Lung Transplantation 44th Annual Meeting
From Paragonix Technologies, Inc.
Via Business Wire
LifeLink of Puerto Rico Utilizes Paragonix Advanced Organ Preservation for Landmark Donor Organ Transport
From Paragonix Technologies, Inc.
Via Business Wire
Expansive Clinical Study Finds Improved Outcomes in Heart Transplant Patients Utilizing Paragonix Advanced Organ Preservation
From Paragonix Technologies, Inc.
Via Business Wire
Record-breaking Donor Heart Transplant Utilizing the Paragonix SherpaPak®
From Paragonix Technologies, Inc.
Via Business Wire
Clinical Study of Over 1,000 Transplant Recipients Demonstrates Improved Clinical Outcomes in Heart Transplantation with the Paragonix SherpaPak
From Paragonix Technologies, Inc.
Via Business Wire
Paragonix LUNGguard™ System Shown to Reduce Hospital Readmission Rates in Lung Transplant Recipients
From Paragonix Technologies, Inc.
Via Business Wire
Clinical Evidence Points to Paragonix SherpaPak as Potential Solution to Expand Donor Heart Pool
From Paragonix Technologies, Inc.
Via Business Wire
Paragonix Technologies Presenting Expansive Organ Transplant Research at the International Society of Heart and Lung Transplantation 2023 Annual Meeting
From Paragonix Technologies, Inc.
Via Business Wire
Paragonix Technologies Raises $24M in Series B Led by Signet Healthcare Partners
From Paragonix Technologies, Inc.
Via Business Wire
Latest Clinical Evidence Points to Paragonix SherpaPak® as a Tool to Reduce Unpredictable, Severe Complications following Heart Transplantation
From Paragonix Technologies, Inc.
Via Business Wire
Paragonix Announces First Pediatric Use of LUNGguard™ System in Groundbreaking “Time Shift” Lung Transplantation Case
From Paragonix Technologies, Inc.
Via Business Wire
Legacy of Life Hawaii Utilizes Paragonix LUNGguard and LIVERguard for Donor Organs in First Transport from Hawaii to California
From Paragonix Technologies, Inc.
Via Business Wire
Clinical Evidence Shows Reduced Costs and Improved Outcomes in Heart Transplantation
From Paragonix Technologies, Inc.
Via Business Wire
Paragonix Launches Comprehensive Digital Platform for Real-Time Tracking of Donor Organs Destined for Transplantation
From Paragonix Technologies, Inc.
Via Business Wire
Paragonix Technologies Celebrates Clinical Milestone of over 2,000 Organs Preserved and Transported for Transplantation
From Paragonix Technologies, Inc.
Via Business Wire
Paragonix Technologies Announces Expanded Adoption of their LIVERguard™ System at the 2022 American Transplant Congress
From Paragonix Technologies, Inc.
Via Business Wire
Paragonix Technologies SherpaPak® Improves 1-Year Survival in Heart Transplant Patients in Real-World Study
From Paragonix Technologies, Inc.
Via Business Wire
Paragonix Technologies Presenting New Organ Preservation Research at the International Society of Heart and Lung Transplantation 2022 Annual Meeting
From Paragonix Technologies, Inc.
Via Business Wire
Paragonix Technologies Announces Launch of the Paragonix Web Portal, Providing Users Access to Critical Organ Preservation Data
From Paragonix Technologies, Inc.
Via Business Wire
Paragonix Technologies Announces Milestone of 1,000 Preserved Donor Heart Transports
From Paragonix Technologies, Inc.
Via Business Wire
Paragonix Technologies Announces Global Registry for Pediatric Donor Heart Preservation; Enrolls First Patient
From Paragonix Technologies, Inc.
Via Business Wire
Paragonix Technologies Announces GUARDIAN-LUNG, the First Global Registry for Studying Donor Lung Preservation
From Paragonix Technologies, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.